This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: Yasushi Nagatomi: Innovator in Pharmaceutical Chemistry
Introduction
Yasushi Nagatomi is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, his work focuses on developing compounds that have therapeutic applications.
Latest Patents
Nagatomi's latest patents include a diaryl-substituted five-membered heterocycle derivative. This invention provides compounds represented by a specific formula, which are useful in treating various medical conditions. Another notable patent involves biaryl derivatives, which relate to a compound that has potential applications in treating convulsions, acute pain, and other cerebral disturbances. These compounds are designed to inhibit mGluR1, making them valuable in the treatment and prevention of conditions such as anxiety and Parkinson's disease.
Career Highlights
Nagatomi is currently associated with Banyu Pharmaceutical Co. Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions that address critical health issues.
Collaborations
Throughout his career, Yasushi Nagatomi has collaborated with notable colleagues, including Hiroshi Kawamoto and Satoru Ito. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Yasushi Nagatomi's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His patents not only reflect his expertise but also hold promise for improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile